Literature DB >> 8513524

Interactions of pre-operative erythromycin administration with general anaesthesia.

P Narchi1, D Benhamou, M Elhaddoury, C Locatelli, H Fernandez.   

Abstract

Previous reports have demonstrated a gastric emptying effect of erythromycin due to a motilin-like mechanism. We studied 50 patients, scheduled for daycase laparoscopy, randomly assigned to one of two groups: Group P patients received 30 min before induction of anaesthesia, in a double-blind manner an infusion of 250 ml dextrose 5% while patients in Group E (n = 25) received 500 mg of erythromycin diluted in 250 ml dextrose 5%. An orogastric tube was inserted to measure both gastric pH using a pHmeter and residual gastric volume (RGV) using the phenol red dilutional technique. Six patients were excluded for surgical reasons. More patients in Group P (6/22) than in Group E (0/22) had RGV > 25 ml and more patients in Group P (17/22) presented with a gastric pH < 2.5 than in Group E (5/22), P < 0.05. Since coma and respiratory depression have been reported recently after midazolam and alfentanil administration in patients having received erythromycin, recovery conditions were assessed and were found to be comparable between groups. In conclusion, the administration of iv erythromycin before outpatient laparoscopy decreased residual gastric volume and increased gastric pH without affecting recovery from general anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513524     DOI: 10.1007/BF03009515

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  10 in total

Review 1.  Prolonged alfentanil effect following erythromycin administration.

Authors:  R R Bartkowski; T E McDonnell
Journal:  Anesthesiology       Date:  1990-09       Impact factor: 7.892

2.  Erythromycin for reflex ileus in Ogilvie's syndrome.

Authors:  D N Armstrong; G H Ballantyne; I M Modlin
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

3.  Unconsciousness associated with midazolam and erythromycin.

Authors:  A Hiller; K T Olkkola; P Isohanni; L Saarnivaara
Journal:  Br J Anaesth       Date:  1990-12       Impact factor: 9.166

4.  Gastric volume and pH in out-patients.

Authors:  B Y Ong; R J Palahniuk; M Cumming
Journal:  Can Anaesth Soc J       Date:  1978-01

5.  Inhibition of alfentanil metabolism by erythromycin.

Authors:  R R Bartkowski; M E Goldberg; G E Larijani; T Boerner
Journal:  Clin Pharmacol Ther       Date:  1989-07       Impact factor: 6.875

6.  New clinical method for measuring the rate of gastric emptying: the double sampling test meal.

Authors:  J D George
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

7.  Erythromycin induces migrating motor complex in human gastrointestinal tract.

Authors:  T Tomomasa; T Kuroume; H Arai; K Wakabayashi; Z Itoh
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

8.  Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog.

Authors:  Z Itoh; M Nakaya; T Suzuki; H Arai; K Wakabayashi
Journal:  Am J Physiol       Date:  1984-12

9.  Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies.

Authors:  J Janssens; T L Peeters; G Vantrappen; J Tack; J L Urbain; M De Roo; E Muls; R Bouillon
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

10.  Development of motilin receptors and of motilin- and erythromycin-induced contractility in rabbits.

Authors:  I Depoortere; T L Peeters; G Vantrappen
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

  10 in total
  2 in total

Review 1.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

2.  Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Authors:  Malene Plejdrup Hansen; Anna M Scott; Amanda McCullough; Sarah Thorning; Jeffrey K Aronson; Elaine M Beller; Paul P Glasziou; Tammy C Hoffmann; Justin Clark; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.